1. K. M. Lakin, V. A. Feldbaum, and A. A. Lebedeva, “Substances decreasing platelet aggregation and adhesiveness. Literature review,” Farmakol. Toksikol., 34, 104–113 (1971).
2. K. M. Lakin, V. A. Feldbaum, and M. S. Ovnatanova, “Effect of some vasoactive substances on platelet aggregation,” Kardiologiya, 12, 21–25 (1972).
3. A. G. G. Turpie and J. Hirsh, “Platelet suppressive therapy,” Br. Med. Bull., 34, 183–190 (1978).
4. L. M. Fuccella, “Clinical pharmacology of inhibitors of platelet aggregation,” Pharmacol. Res. Commun., 11, 825–852 (1979).
5. D. R. Feller, S. S. Navran, J. R. Mayro, et al., “Differential stereoselective inhibition by trimetoquinol (TMQ) of platelet aggregation mediated by prostaglandin dependent and independent pathways,” in: Eighth International Congress of Pharmacology, Tokyo (1981), Abstract, p. 585.